Back to News
Market Impact: 0.25
Inspire Secures AMA Approval For New Hypoglossal Nerve Stimulation Codes
Source: Nasdaq
Healthcare & BiotechRegulation & LegislationProduct Launches
Inspire Medical Systems announced that the American Medical Association's CPT Editorial Panel approved new CPT codes for hypoglossal nerve stimulation procedures, including procedures involving its Inspire V system. The coding approval is a positive reimbursement and adoption-related milestone for the company's sleep-apnea therapy platform, though the article provides no financial impact or implementation timeline.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.35
Ticker Sentiment
INSP0.55
More News
- Mark Ruffalo says Paramount’s $111 billion Warner Bros. deal ‘Will stifle creativity, weaken free speech, and cost people their jobs’
- States, cities sue U.S. agencies over weaker vehicle fuel economy rules
- Anthropic warns government attitudes may hurt customer ties, IPO prospectus shows: Reuters
- Paramount and Warner Bros Discovery to become Skydance
- FAA says Boeing 737 Max software glitch not a flight-safety issue
- Paramount’s Warner Bros. megamerger will just be called Skydance